Purpose: Irritable Bowel Syndrome (IBS) represents one of the largest and most commercially significant segments within functional gastroenterology, with the gut–brain axis playing a central role in symptom development and management. Increasing recognition of the interaction between gastrointestinal function, stress, mood, and the nervous system has driven demand for integrated IBS care models.
Upload here: https://gastroenterology-hepatology.utilitarianevents.com/upload-presentation/
WhatsApp: https://wa.me/+971551792927
Email: info-ucg@utilitarianconferences.com
Keynote Points:
High global prevalence and chronic nature of IBS
Growing focus on gut–brain signaling and neurogastroenterology
Demand for neuromodulators, probiotics, and microbiome-based therapies
Expansion of digital therapeutics, CBT-based apps, and virtual care
Strong market for dietary interventions and personalized nutrition
Rising patient acceptance of integrative and holistic IBS management
Collaboration opportunities across GI, mental health, and digital health
Benefits:
Large, recurring patient population with long-term care needs
Multiple revenue streams across pharma, wellness, nutrition, and digital platforms
High patient engagement supporting subscription and program-based models
Strong differentiation through integrated gut–brain care solutions
Attractive ROI aligned with chronic disease management
Positions brands at the forefront of next-generation functional GI care